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Safety of Overlapping Inpatient Orthopaedic Surgery
A Multicenter Study
Christopher J. Dy, MD, MPH,* Daniel A. Osei, MD, MSc,* Travis G. Maak, MD, Michael B. Gottschalk, MD, Alan L. Zhang, MD,
Michael D. Maloney, MD, Angela P. Presson, PhD, MS, and Regis J. O’Keefe, MD, PhD
Investigation performed at the Department of Orthopaedic Surgery and Division of Public Health Sciences, Department of Surgery, Washington
University School of Medicine, St. Louis, Missouri
Background: Although overlapping surgery is used to maximize efﬁciency, more empirical data are needed to guide
patient safety. We conducted a retrospective cohort study to evaluate the safety of overlapping inpatient orthopaedic
surgery, as judged by the occurrence of perioperative complications.
Methods: All inpatient orthopaedic surgical procedures performed at 5 academic institutions from January 1, 2015, to
December 31, 2015, were included. Overlapping surgery was deﬁned as 2 skin incisions open simultaneously for
1 surgeon. In comparing patients who underwent overlapping surgery with those who underwent non-overlapping surgery,
the primary outcome was the occurrence of a perioperative complication within 30 days of the surgical procedure, and
secondary outcomes included all-cause 30-day readmission, length of stay, and mortality. To determine if there was an
association between overlapping surgery and a perioperative complication, we tested for non-inferiority of overlapping
surgery, assuming a null hypothesis of an increased risk of 50%. We used an inverse probability of treatment weighted
regression model adjusted for institution, procedure type, demographic characteristics (age, sex, race, comorbidities),
admission type, admission severity of illness, and clustering by surgeon.
Results: Among 14,135 cases, the frequency of overlapping surgery was 40%. The frequencies of perioperative com-
plications were 1% in the overlapping surgery group and 2% in the non-overlapping surgery group. The overlapping surgery
group was non-inferior to the non-overlapping surgery group (odds ratio [OR], 0.61 [90% conﬁdence interval (CI), 0.45 to
0.83]; p < 0.001), with reduced odds of perioperative complications (OR, 0.61 [95% CI, 0.43 to 0.88]; p = 0.009). For
secondary outcomes, there was a signiﬁcantly lower chance of all-cause 30-day readmission in the overlapping surgery
group (OR, 0.67 [95% CI, 0.52 to 0.87]; p = 0.003) and shorter length of stay (eb, 0.94 [95% CI, 0.89 to 0.99]; p = 0.012).
There was no difference in mortality.
Conclusions: Our results suggest that overlapping inpatient orthopaedic surgery does not introduce additional periop-
erative risk for the complications that we evaluated. The suitability of this practice should be determined by individual
surgeons on a case-by-case basis with appropriate informed consent.
Level of Evidence: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.
O
verlapping surgery refers to “operations performed by
the same primary surgeon such that the start of one
surgery overlaps with the end of another.”1 This long-
standing practice has been used by surgeons and hospitals to
maximize operating room efﬁciency, with the additional beneﬁt
of allowing graduated responsibility to surgical trainees. This
practice has been criticized, citing concerns with regard to
patient safety, informed consent, and strain to the doctor-patient
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relationship. Advocates for overlapping surgery cite its increased
efﬁciency, its ability to increase availability of specialist surgeons,
and an anecdotal belief in safety. Critics of overlapping surgery
point to a lack of empirical evidence demonstrating safety and
the threat that this practice creates to public trust in hospitals
and surgeons2 as well as concerns from bioethical, profession-
alism, and legal perspectives3.
Since investigative journalists at The Boston Globe brought
the practice of overlapping surgery to public attention in 20154,
single-center studies have evaluated the safety of overlap in
ambulatory orthopaedic surgery5, inpatient surgery for hip
fracture and arthritis6, and inpatient neurosurgery7-9. With the
exception of Ravi et al.6, each of these studies demonstrated that
overlapping surgery was not associated with a signiﬁcant dif-
ference in perioperative outcomes. All studies included meth-
odological limitations in risk stratiﬁcation, generalizability, and
statistical power. Using both administrative data and clinical
registries to address these shortcomings, Hyder et al. examined
all inpatient operations over 3 years at the Mayo Clinic10. They
concluded that overlapping surgery was safe at their center, but
acknowledged limitations in generalizability of their ﬁndings.
In their population-based, matched-cohort study with a small
frequency of overlapping surgery (2.5% of hip fracture oper-
ations and 3% of total hip arthroplasties) and without adjust-
ment for comorbidities, Ravi et al. demonstrated an increased
risk of complications in the overlapping surgery group.
Given the need for additional empirical data to guide
stakeholders and policymakers seeking to protect patient safety,
we conducted a cohort study to evaluate the safety of overlapping
surgery, as judged by the occurrence of perioperative compli-
cations. Data were combined from 5 academic institutions to
meet sample size needs, to provide rigorous risk adjustment, and
to improve generalizability. We hypothesized that overlapping
surgery would be non-inferior to non-overlapping surgery with
respect to perioperative complications.
Materials and Methods
Following approval from each institution’s review board, wecreated a retrospective cohort of all inpatient operations
performed by orthopaedic surgery faculty members at 5 U.S.
academic medical centers from January 1, 2015, to December
31, 2015. We selected this time period to minimize potential
practice changes following The Boston Globe publication that
could adversely bias study data. At each institution, data were
gathered from the Vizient Clinical Data Base/Resource Man-
ager (CDM/RM) and operating room databases. Vizient CDM/
RM includes case-speciﬁc information including age, race, eth-
nicity, payer, primary and additional procedure codes (including
a Clinical Classiﬁcation Software [CCS] category for the primary
procedure)11, diagnosis codes, admission status, and surgeon.
Case-speciﬁc risk stratiﬁcation parameters (admission severity
of illness, admission relative expected mortality, diagnosis-
related-group-speciﬁc expected mortality, and expected length
of stay [the ﬁrst calculated by 3M and latter 3 calculated by
Vizient]) were also captured. The diagnosis codes for each case
were examined to tabulate an Elixhauser comorbidity index for
each patient12. Procedure codes and the corresponding CCS
category were grouped into 6 clinically relevant subcategories
(total joint arthroplasty, spine surgery, fracture treatment,
other procedures of bone or joint, soft-tissue procedures, and
other) by 2 orthopaedic surgeons. Surgery start (incision) and
end (skin closure) times were extracted for each case from each
medical center’s operating room database. Overlapping surgery
was deﬁned as skin incisions open for 2 cases simultaneously
with the same attending surgeon. The occurrence and duration
of overlapping surgery were tabulated on the basis of surgeon
identiﬁer (Fig. 1). The exact events occurring during overlap
periods (such as surgical approach, preparation for implants,
implantation, or skin closure) were not available with these
data, making it impossible to reliably discern whether critical
portions of the operations were occurring at the same time. We
were also unable to determine how cases were selected by
surgeons or hospitals for overlapping scheduling. Additionally,
the data set did not provide reliable information across insti-
tutions about the level of training of the ﬁrst assistant in each
surgical procedure. The data-sharing agreement among the
institutions did not allow us to publicly share the number of
cases or the case types or mix performed at each institution.
Primary and secondary clinical outcomes data were ex-
tracted from Vizient CDM/RM. Our primary outcome was the
occurrence of a perioperative complication, deﬁned as either an
Agency for Healthcare Research and Quality Patient Safety
Fig. 1
Identiﬁcation of overlapping surgeries (skin incision open for 2 cases simultaneously with the same attending surgeon) using skin incision, skin closure,
and surgeon identiﬁer information.
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Indicator (PSI)13 or a Centers for Medicare &Medicaid Services
Hospital Acquired Condition (HAC)14, both publicly reported
measures for quality of care, within 30 days of the surgical
procedure. Our secondary outcomes were all-cause 30-day
same-hospital readmission, inpatient mortality, and length of
stay. Data-sharing agreements prohibit identiﬁcation of indi-
vidual institutions in the presentation of our analysis.
Statistical Methods
Descriptive statistics were used to characterize demographic
and clinical characteristics. Categorical variables were sum-
marized by counts and percentages, and continuous variables
were summarized by the mean and standard deviation or the
median and interquartile range. We evaluated our primary re-
search question of whether overlapping surgery was non-inferior
to non-overlapping surgery in terms of perioperative complica-
tions using a non-inferiority test in a propensity score-adjusted
weighted outcome model, as detailed below. We also compared
our perioperative complications among cases that were non-
overlapping, overlapping for £30 minutes, and overlapping for
>30 minutes using a chi-square test.
Power Calculation
For our primary outcome of 30-day complication rate, we
deﬁned our non-inferiority margin as 1.5 times the non-
overlapping surgery group rate, and we based our a priori
sample size calculation on an overall complication rate of 1.6%
from the examination of preliminary data from 1 institution.
Expecting an overlapping surgery rate of about 50%, under the
null hypothesis, our complication rates were ‡1.92% in the
overlapping surgery group and 1.28% in the non-overlapping
surgery group. On the basis of these rates, we projected 90%
power at a signiﬁcance level of p < 0.05 to detect non-
inferiority with 5,284 patients per group or 10,568 total cases.
The rationale for a non-inferiority test was that we
expected complication rates to be similar between the over-
lapping surgery group and the non-overlapping surgery group.
However, we would not want to penalize the overlapping sur-
gery group if it had fewer complications than the non-
overlapping surgery group. Thus, a non-inferiority test enabled
us to test whether the overlapping surgery group was not
substantially worse than the non-overlapping surgery group in
terms of complication rates. We did not perform power cal-
culations for secondary outcomes of length of stay, mortality,
and 30-day readmissions.
Modeling Approach
We used an inverse probability of treatment weighting ap-
proach rather than conventional multivariable logistic regres-
sion because we expected too few complication events to
support a logistic regression model that adjusted for all co-
variates (using the 10 events per predictor rule of thumb)15.
Our propensity model used multivariable logistic regression
predicting overlapping or non-overlapping status from all
potential variables related to overlapping or non-overlapping
status that were available. These included institution, proce-
dure type, patient demographic characteristics (age, sex, race,
comorbidities), admission type, and admission severity of ill-
ness. Propensity score distributions were plotted to show the
overlap between patients who underwent overlapping surgery
and those who underwent non-overlapping surgery. Propensity
scores were used to calculate the average treatment effect in
treated weights for each subject i, usingWi = Zi1 ei · (12 Zi)/
(12 ei), where Zi = 1 indicates overlapping surgery (and Zi = 0,
non-overlapping) and ei indicates the propensity weight
16.
The balance in covariates after adjustment for the average
treatment effect in treated weights was checked using stan-
dardized differences, calculated using an absolute difference in
sample means between subjects in the overlapping and non-
overlapping surgery groups divided by their pooled standard
deviation17. Our primary outcome model predicted periop-
erative complications from overlapping or non-overlapping
surgery status using generalized estimating equation (GEE)
logistic regression with robust standard errors and an ex-
changeable correlation matrix to adjust for the correlation of
outcomes within surgeons (clustering within surgeons). We
considered a model that nested procedures within surgeons,
but it did not converge. The model was implemented in R using
the geeglm() function from the geepack package, with the
“weights” option to utilize the average treatment effect in
treated weights. We also adjusted for important covariates in
our outcome model, including procedure type, admission
severity of illness, and institution, as recommended to reduce
bias from uncontrolled confounding18. We ran this model
with and without including interactions between institution
and overlapping surgery status and between institution and
procedure type to allow for the relationship between these
variables and complications to vary by institution. We ran a
sensitivity analysis dropping the institution with the fewest
non-overlapping surgery cases, in case decisions to perform
overlapping surgery differed for this institution. This resulted
in 12,577 patients from 4 institutions. We ran a second sensi-
tivity analysis for the most common procedure, total joint
arthroplasty. This analysis reduced our sample size by 57% to
6,083 patients. It removed potential confounding due to pro-
cedure type at the cost of decreased power and generalizability.
We ran a third sensitivity analysis that only included surgeons
who performed overlapping surgery. This analysis reduced our
sample size to 12,889 patients. It minimized potential con-
founding due to surgeon workﬂow preferences or practices. We
ran a fourth sensitivity analysis that excluded patients with
propensity scores of <0.2 and >0.8 from the GEE model. This
analysis reduced our sample size to 10,676 patients. It mini-
mized potential confounding due to surgeon workﬂow pref-
erences or practices.
Secondary outcomes (all-cause 30-day same-hospital
readmission, inpatient mortality, and length of stay) were
similarly analyzed in outcome models with the average treat-
ment effect in treated weights and adjusting for clustering
by surgeon, but we used conventional 2-sided statistical tests
to assess signiﬁcance rather than non-inferiority tests. Our
rationale was that these were secondary outcomes, and
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(N = 8,439) P Value Test
Age (yr)
Mean and standard deviation 59.4 ± 15.5 56.4 ± 18.5 <0.001 T test
Median (interquartile range) 62 (52, 70) 60 (46, 69)
Female sex 2,842 (50%) 4,037 (48%) 0.016 Chi-square
Race <0.001 Chi-square
White 4,588 (81%) 6,651 (79%)
Asian 70 (1%) 219 (3%)
Black 791 (14%) 876 (10%)
Declined 19 (0%) 14 (0%)
Other 194 (3%) 532 (6%)
Unavailable 24 (0%) 81 (1%)
Unknown 10 (0%) 66 (1%)
Payer <0.001 Chi-square
Private 2,516 (44%) 3,306 (39%)
Medicare 2,453 (43%) 3,514 (42%)
Medicaid 338 (6%) 920 (11%)
Government: other 15 (0%) 24 (0%)
Veterans Affairs or TRICARE 94 (2%) 123 (1%)
Workers’ Compensation 82 (1%) 245 (3%)
Other, self-pay, or unknown 198 (3%) 307 (4%)
Admission status <0.001 Chi-square
Elective 4,048 (71%) 4,511 (53%)
Emergency 364 (6%) 1,934 (23%)
Trauma center 439 (8%) 556 (7%)
Urgent 845 (15%) 1,438 (17%)
Elixhauser comorbidities
Mean and standard deviation 1.9 ± 1.9 2 ± 2.1
Median (interquartile range) 1 (1, 3) 1 (0, 3) 0.18 Wilcoxon
Range 0 to 17 0 to 17
Severity of illness at admission <0.001 Chi-square
Extreme 118 (2%) 282 (3%)
Major 560 (10%) 1,211 (14%)
Moderate 2,789 (49%) 3,920 (46%)
Minor 2,229 (39%) 3,026 (36%)
Relative expected mortality at admission <0.001 Chi-square
Extreme 75 (1%) 139 (2%)
Major 145 (3%) 492 (6%)
Moderate 909 (16%) 1,529 (18%)
Minor 4,567 (80%) 6,279 (74%)
Surgical procedure type <0.001 Chi-square
Total joint replacement 3,483 (61%) 2,600 (31%)
Spine 869 (15%) 2,025 (24%)
Fracture treatment 700 (12%) 1,928 (23%)
Other procedures of bone or joint 378 (7%) 1,005 (12%)
Soft-tissue procedures 212 (4%) 668 (8%)
Other 54 (1%) 213 (3%)
continued
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developing non-inferiority tests would require non-inferiority
margins to be determined for each outcome, based on evidence
provided in the literature. We also provide a conventional 2-
sided statistical test result for our primary outcome (compli-
cations) to allow for comparability with our secondary out-
comes. The inpatient mortality outcome model only included
admission severity of illness as a covariate because there were
too few events to additionally support institution and proce-
dure type. Because of skewing of the distribution, we used
gamma regression for the evaluation of length of stay, and the
coefﬁcients and 95% conﬁdence intervals (CIs) were ex-
ponentiated (eb) for interpretation as ratios. Signiﬁcance was
assessed at p < 0.05 and, aside from our 1-sided non-inferiority
test for perioperative complications, all tests were 2-sided.
Statistical analysis was performed in R version 3.4 (R Foun-
dation for Statistical Computing). Additional information with
regard to implementation of the non-inferiority analysis is
included in the Appendix.
Results
There were 14,135 operations performed by 215 surgeons(range, 15 to 76 surgeons among the 5 institutions).
Overlapping surgery (skin incisions open in 2 separate rooms)
of any duration occurred in 40% of surgical procedures.
Among those cases with overlapping surgery, the mean dura-
tion of overlapping surgery was 53 minutes and the median
duration of overlapping surgery was 37 minutes (interquartile
range, 17 to 71minutes). Differences in age, sex, race, and payer
between groups are demonstrated in Table I. There were sig-
niﬁcantly more elective cases (p < 0.001) in the overlapping
surgery group (71%) compared with the non-overlapping
surgery group (53%). There was a signiﬁcantly higher pro-
portion of total joint replacement cases (p < 0.001) in the
overlapping surgery group (61%) compared with the non-
overlapping surgery group (31%). The combined percentage of
patients with extreme ormajor admission severity of illness was
12% in the overlapping surgery group and 17% in the non-
overlapping surgery group (p < 0.001) (Table I). Relative
expected mortality at admission and diagnosis-related-group-
speciﬁc expected mortality were lower in the overlapping sur-








(N = 8,439) P Value Test
Expected length of stay* (d) 3 (2.5, 4) 3.7 (2.7, 5.8) <0.001 Wilcoxon
Diagnosis-related-group-speciﬁc expected mortality (%)
Mean and standard deviation 0.3 ± 2.1 0.6 ± 3.1
Median (interquartile range) 0.1 (0, 0.2) 0.1 (0, 0.3) <0.001 Wilcoxon
Range 0 to 98.2 0 to 82.4
Primary outcome
Patient Safety Indicator or Hospital Acquired Condition 57 (1%) 156 (2%) <0.001 Chi-square
Secondary outcomes
Readmission within 30 days for any reason 84 (1%) 358 (4%) <0.001 Chi-square
Inpatient mortality 9 (0%) 34 (0%) 0.01 Chi-square
Length of stay* 2 (1, 3) 3 (2, 5) <0.001 Wilcoxon
*The values are given as the median and the interquartile range.
Fig. 2
Propensity score distributions between the overlapping surgery (OverSx:
lavender) group and the non-overlapping surgery (No OverSx: peach) group
show notable overlap (overlap indicated in purple). There were 5 subjects
with scores outside the overlapping region who were dropped from our
analysis. The area of the distributions was scaled to be equal between the
groups to improve visualization.
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Univariate analysis demonstrated a signiﬁcantly lower fre-
quency of perioperative complications in the overlapping surgery
group (1% [57 events among 5,696 cases]) than in the non-
overlapping surgery group (2% [156 events among 8,439 ca-
ses]). Similarly, there was a signiﬁcant difference (p < 0.001) in
perioperative complications among non-overlapping surgery
cases (1.8%), cases overlapping for £30 minutes (0.9%), and
cases overlapping for >30 minutes (1.1%). Inpatient mortality
was uncommon in both groups (43 events total: 9 in the
overlapping surgery group and 34 in the non-overlapping
surgery group; p = 0.01). Thirty-day all-cause hospital read-
mission was lower (p < 0.001) in the overlapping surgery group
(1%) than in the non-overlapping surgery group (4%). The
observed length of stay was also lower in the overlapping sur-
gery group (median, 2 days [interquartile range, 1 to 3 days])
than in the non-overlapping surgery group (median, 3 days
[interquartile range, 2 to 5 days]).
Overlap was high between propensity score distributions
of those with and without overlapping surgery (Fig. 2), except
for 5 subjects who had scores outside of the overlap region and
were dropped from our analysis. Inverse probability of treat-
ment weighting19 achieved balance (standardized difference
Fig. 3
Standardized differences between overlapping and non-overlapping surgery groups for all covariates included in the regression model. Standardized
differences were calculated as the absolute difference in the sample means between the overlapping and non-overlapping surgery groups divided by their
pooled standard deviation. Light purple indicates standardized differences with adjustment using inverse probability of treatment weighting, and blue
indicates standardized differences without adjustment. All standardized differences with adjustment (light purple) are <0.2, indicating balance among the
covariates between the 2 groups. Work Comp = Workers’ Compensation and VA = Veterans Affairs.
1907
THE JOURNAL OF BONE & JOINT SURGERY d J B J S .ORG
VOLUME 100-A d NUMBER 22 d NOVEMBER 21, 2018
SAFETY OF OVERLAPP ING INPAT IENT ORTHOPAED IC SURGERY
<0.2) in all measured covariates, indicating that the over-
lapping surgery group and the non-overlapping surgery group
were similar with regard to covariates after weighting was
applied (Fig. 3). Our outcome regression model, adjusting for
the average treatment effect in treated weights and potential
confounders, demonstrated that the overlapping surgery group
was non-inferior with regard to perioperative complications
(odds ratio [OR], 0.61 [90% CI, 0.45 to 0.83]; p < 0.001
compared with an OR of 1.51 in a non-inferiority test). Fur-
thermore, conventional hypothesis testing showed a signiﬁ-
cantly reduced odds of perioperative complications in the
overlapping surgery group (OR, 0.61 [95% CI, 0.43 to 0.88]; p
= 0.009). The risk of perioperative complications was associ-
ated with institution, procedure type (with all other procedure
types associated with greater risk than total joint arthroplasty),
and admission severity of illness (with a direct association of
greater severity of illness with perioperative complications)
(Table II). The relationship between overlapping surgery and
complications was similar in magnitude and signiﬁcance in the
models with and without interactions between institution and
overlapping surgery status and between institution and pro-
cedure type (data not shown). The results for the secondary
outcomes of 30-day all-cause readmission demonstrated sig-
niﬁcantly lower odds of readmission in the overlapping surgery
group (OR, 0.67 [95% CI, 0.52 to 0.87]; p = 0.003) and a
shorter length of stay (eb, 0.94 [95% CI, 0.89 to 0.99]; p =
0.012) after adjusting for institution, procedure type, and
admission severity of illness (Table III). After adjusting for
admission severity of illness, there was no difference in the odds
of inpatient mortality (OR, 1.05 [95% CI, 0.54 to 2.47]; p =
0.71).
Sensitivity Analyses
We performed a sensitivity analysis in which 1 institution with
a lower percentage of overlapping cases was excluded. The
results (reported in the Appendix) were similar to the full
model with regard to coefﬁcient direction and signiﬁcance. We
performed an additional sensitivity analysis including only
patients who underwent total hip or knee arthroplasty. For this
analysis, we again found the overlapping surgery group to be
non-inferior to the non-overlapping surgery group, with a
less pronounced effect (8% lower odds of complications [OR,
0.92 (90% CI, 0.6 to 1.43); p = 0.032]). With conventional
hypothesis testing, the complication rate was not signiﬁcantly
different between the overlapping surgery group and the non-
overlapping surgery group (OR, 0.92 [95% CI, 0.55 to 1.55]; p
= 0.76). We performed a third sensitivity analysis including
only surgeons who performed overlapping surgery. For this
analysis, we again found the overlapping surgery group to be
non-inferior to the non-overlapping surgery group, with a
slightly less pronounced effect (OR, 0.61 [90% CI, 0.45 to
0.83]; p = 0.008). With conventional hypothesis testing, the
complication rate was signiﬁcantly lower in the overlapping
surgery group compared with the non-overlapping surgery
group (OR, 0.61 [95% CI, 0.42 to 0.88]; p < 0.001). In our
fourth sensitivity analysis, removing patients with a propensity
score of <0.2 or >0.8 from the model, we again found the
TABLE II GEE Model for the Primary Outcome, Weighted by
Propensity Scores and Adjusting for Clustering
within Surgeons*
Variable OR* P Value
Overlapping surgery† 0.61 (0.43 to 0.88) 0.009
Institution
Institution 1 1.27 (0.54 to 2.96) 0.58
Institution 2 2.77 (1.62 to 4.73) <0.001
Institution 3 Reference
Institution 4 0.51 (0.26 to 1.01) 0.054
Institution 5 0.52 (0.31 to 0.86) 0.012
Surgical procedure type
Total joint replacement Reference
Spine 2.89 (1.69 to 4.94) <0.001
Fracture treatment 1.58 (0.81 to 3.05) 0.18
Other procedures
of bone or joint
2.68 (1.34 to 5.35) 0.005
Soft-tissue procedures 3.86 (1.97 to 7.57) <0.001




Moderate 2.30 (1.31 to 4.06) 0.004
Major 5.20 (2.52 to 10.73) <0.001
Extreme 25.41 (12.09 to 53.40) <0.001
*The values are given as the OR, with the 95% CI in parentheses,
for conventional hypothesis testing.†For our non-inferiority testing
of overlapping surgery, the OR (and 90% CI) was 0.61 (0.45 to
0.83), and the 1-sided p value was p < 0.001.
TABLE III GEE Model for the Secondary Outcomes of All-Cause






Length of stay* 0.94 (0.89 to 0.99)† 0.012
All-cause 30-day hospital
readmission*
0.67 (0.52 to 0.87)‡ 0.003
Inpatient mortality§ 1.05 (0.54 to 2.47)‡ 0.71
*The models for all-cause 30-day hospital admission and length of
stay are adjusted for institution, procedure type, and admission
severity of illness. †The value is given as the ratio in outcomes
(with the 95% CI in parentheses) between the overlapping surgery
group and the non-overlapping surgery group. ‡The values are
given as the odds ratio, with the 95% CI in parentheses. §Because
of the low number of inpatient deaths (43 cases total), the model
for inpatient mortality adjusts only for the admission severity of
illness.
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overlapping surgery group to be non-inferior to the non-
overlapping surgery group, with a slightly less pronounced
effect (OR, 0.61 [90% CI, 0.42 to 0.90]; p = 0.012). With
conventional hypothesis testing, the complication rate was
signiﬁcantly lower in the overlapping surgery group compared
with the non-overlapping surgery group (OR, 0.61 [90% CI,
0.44 to 0.84]; p < 0.001).
Discussion
Perioperative risk is multifactorial, with numerous patient,procedure, surgeon, and hospital-speciﬁc factors contrib-
uting to the overall safety of an individual operation20. As
demonstrated in our multivariable analysis of inpatient or-
thopaedic operations, patient comorbidities, procedure type,
and institution were all signiﬁcantly associated with the like-
lihood of a postoperative patient safety event. After adjusting
for these factors, we demonstrated that having overlapping
surgery was not an independent risk factor for perioperative
patient safety events. We found that patients who had over-
lapping surgery were at signiﬁcantly lower risk of patient safety
events and 30-day all-cause readmission; these ﬁndings likely
reﬂect characteristics inﬂuencing surgical outcomes that we
cannot reliably measure with these data, such as individual
procedure complexity and surgeon experience. Using admin-
istrative data, we cannot reliably determine the complexity of
cases and therefore cannot examine the relationship between
case complexity and overlap. Future investigation into reasons
for a lower complication rate among patients having over-
lapping surgery are warranted, but are beyond the scope of this
investigation.
A relatively small portion of the surveyed public is aware
of the practice of overlapping surgery21. Empirical investigation
with regard to the safety of overlapping surgery is needed to
justify the perceived risks associated with it. Prior single-center
studies have demonstrated the relative safety of overlapping
surgery5,7-10, and our study was designed to address methodo-
logical limitations of prior studies (including risk stratiﬁcation,
statistical power, and approach to hypothesis testing). Our
results corroborate those of most prior studies, lending further
credence to the belief that overlapping surgery itself is not an
independent risk factor for an adverse outcome. Our ﬁndings
are in contrast to those of Ravi et al., who demonstrated an
increased risk of complications in patients undergoing hip
fracture surgery or total hip arthroplasty in Ontario, Canada6.
The populations assessed in our study and the study by Ravi
et al. may be inherently different because of contrasts in health-
care systems (most strikingly, the overlapping surgery rate was
40% in the former and 2.5% to 3% in the latter) and the
breadth of procedures studied (all inpatient orthopaedic sur-
gery in our study; only hip fracture surgery and total hip
arthroplasty in the study by Ravi et al.). However, the subgroup
analysis that we conducted, which only included patients who
underwent total hip or knee arthroplasty, demonstrated a
similar lack of increased risk in the overlapping surgery group.
We have also included adjustment for perioperative medical
risk in our regression models.
As surgeons and hospitals determine the role and ap-
propriateness of overlapping surgery at their institutions, it
should be noted that the public desires greater transparency
about the rationale and processes of overlapping surgery21,22.
Mello and Livingston provided guidance for communicating
with patients, suggesting that a discussion be conducted in
advance of surgery about the surgeon’s exact involvement in the
surgery, the potential delegation of some surgical responsibility
to trainees or assistants, and the possibility of overlapping
surgery2. Furthermore, a recent update to the American College
of Surgeons Statement on Principles makes clear the expecta-
tions for surgeons with regard to the conduct of overlapping
surgery and securing informed consent23.
The current investigation had limitations inherent to its
study design. We used an administrative data source to obtain
the sample size needed to examine non-inferiority of over-
lapping surgery. The use of Vizient data for clinical outcomes
provided uniformity of reporting across institutions, but it relies
on accuracy of coding and validity of outcomes measures. Prior
validation of a Vizient clinical database with institutional data
has demonstrated reliability in reporting demographic char-
acteristics and postoperative complications24. Additionally, we
used risk adjustment parameters (such as admission severity of
illness and expected mortality) that were created by third
parties (3M and Vizient). We did not independently validate
these risk adjustment parameters, but they are used at academic
institutions for peer benchmarking and have been utilized in other
empirical studies of inpatient and perioperative outcomes25,26.
Although our study evaluated the effect of overlapping surgery on
measures of postoperative patient safety, we acknowledge that the
effect of overlapping surgery on patient satisfaction and longer-
term (>30-day) patient outcomes (including revision surgery
rates and radiographic assessments such as implant alignment)
remains unclear. Although we performed an analysis based on
the amount of overlap, we did not have any information with
regard to which steps were occurring during overlapping times
(because it is not the current practice at our institutions to
record when the critical portions of surgical procedures are
occurring). As institutions move toward more granular record-
keeping of events during surgical procedures and form policies
with regard to the critical portions of the surgical procedure,
the duration and type of overlap deserve future investigation1.
Additionally, our analysis indicates that there are many other
factors that contribute to perioperative complications. Procedure
type may play an important role in determining the appropri-
ateness of overlapping surgery. In our second sensitivity analysis,
we performed an analysis of total hip or knee arthroplasty that
resulted in similar ﬁndings (but to a lesser extent). Prior lit-
erature has demonstrated the importance of surgeon volume as
it relates to complications and outcomes27,28. Privacy consid-
erations in our data-sharing agreements prohibit stratiﬁcation
of outcomes by individual surgeons, but we adjusted for
the correlation of outcomes within surgeons. Furthermore, the
implications of overlapping surgery likely extend beyond
the short-term perioperative complications that we analyzed;
future investigation must include long-term patient-reported
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outcomes. Lastly, our ﬁndings are based on an analysis of data
for inpatient orthopaedic surgery cases in the United States.
The varying risk proﬁles of other types of surgery (outpatient
or ambulatory surgery, different surgical disciplines) should
be considered before our ﬁndings are generalized or applied
broadly.
Although perioperative risk depends on numerous other
factors, our results provide empirical data indicating that
overlapping inpatient orthopaedic surgery is non-inferior with
regard to the occurrence of postoperative patient safety events.
It is acknowledged that overlapping surgery is a high-stakes
form of multitasking for both surgeon and staff2. Individual
surgeons must make a determination whether they can ade-
quately supervise operations that overlap in 2 separate rooms.
In addition to the category of procedure, the complexity of
individual procedures (such as primary total joint arthroplasty
compared with tumor reconstruction arthroplasty) likely has a
large inﬂuence on the selection of cases for overlapping surgery.
When performed at its optimal capacity, overlapping surgery
can be beneﬁcial to all parties involved, provided that appro-
priate measures are taken to prioritize patient safety, to ensure
informed consent, and to eliminate the chance of concurrent
surgery (in which critical portions of the cases occur simulta-
neously23). Although the practice of scheduling overlapping
cases may have the appearance of only serving the surgeon and/
or hospital, this increase in surgical capacity can also be seen as
improving access to care for patients desiring a surgical pro-
cedure sooner. Our model indicates that other factors (patient,
procedure, and institution-speciﬁc) are associated with post-
operative complications, suggesting that the appropriateness of
overlapping surgery is potentially case-speciﬁc. Because patient
awareness of the rationale and logistics of this practice is lacking,
additional studies are needed to evaluate both patient under-
standing and acceptance of overlapping surgery. It is incumbent
on surgeons who perform overlapping surgery to disclose this
practice to their patients and to collect patient-reported out-
comes to ensure continuing patient satisfaction and to demon-
strate beneﬁt to society.
Appendix
Text describing the non-inferiority analysis implementation
and the 4 sensitivity analyses along with tables showing the
GEE models for these outcomes are available with the online
version of this article as a data supplement at jbjs.org (http://links.
lww.com/JBJS/E959). n
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